Overview

A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model

Status:
Completed

Trial end date:
2014-07-01

Target enrollment:

Participant gender:

Summary

This study is designed to compare the antiviral effect of ALS-008176 compared to a placebo control in the respiratory syncytial virus challenge model.

Phase:

Phase 2

Details

Lead Sponsor:

Alios Biopharma Inc.